Janus Henderson Investors US’s Bio-Rad Laboratories Class A BIO Stock Holding History

Janus Henderson Investors US’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$2.47M	Buy	12,400 +5,300	+75%	+$1.02M	﹤0.01%	901
2016 Q4	$1.29M	Sell	7,100 -200	-3%	-$34.1K	﹤0.01%	1022
2016 Q3	$1.2M	Sell	7,300 -600	-8%	-$91.1K	﹤0.01%	1011
2016 Q2	$1.13M	Sell	7,900 -9,000	-53%	-$1.28M	﹤0.01%	984
2016 Q1	$2.31M	Sell	16,900 -16,600	-50%	-$2.18M	﹤0.01%	893
2015 Q4	$4.64M	Buy	33,500 +15,500	+86%	+$2.15M	﹤0.01%	834
2015 Q3	$2.42M	Buy	18,000 +15,100	+521%	+$2.17M	﹤0.01%	924
2015 Q2	$437K	Buy	+2,900	New	+$415K	﹤0.01%	1046

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Janus Henderson Investors US's BIO Position: Q1 2017 in Review

Janus Henderson Investors US increased its Bio-Rad Laboratories Class A (BIO) stake by 75% in Q1 2017, buying an estimated $1.02M and bringing the position to 12,400 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #901.

Janus Henderson Investors US first reported a position in BIO in Q2 2015 and has held it in 8 quarters since. The position peaked at $4.64M in Q4 2015. 274 funds tracked by Wall St. Rank hold BIO as of Q1 2017.

Janus Henderson Investors US held 12,400 shares of Bio-Rad Laboratories Class A worth $2.47M as of Q1 2017.
Janus Henderson Investors US bought 5,300 Bio-Rad Laboratories Class A shares in Q1 2017, an estimated $1.02M.
Bio-Rad Laboratories Class A made up ﹤0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #901 holding.
Janus Henderson Investors US first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and has held it in 8 quarters since.
Janus Henderson Investors US's Bio-Rad Laboratories Class A position peaked at $4.64M in Q4 2015.
274 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.